The production of diffraction-quality protein crystals is challenging and often requires bespoke, time-consuming and expensive strategies. A system has been developed in which the BCL6 BTB domain acts as a crystallization chaperone and promiscuous assembly block that may form the basis for affinity-capture crystallography. The protein of interest is expressed with a C-terminal tag that interacts with the BTB domain, and co-crystallization leads to its incorporation within a BTB-domain lattice. This strategy was used to solve the structure of the SH3 domain of human nebulin, a structure previously solved by NMR, at 1.56 Å resolution. This approach is simple and effective, requiring only routine protein complexation and crystallization screen...
Inherent difficulties in growing protein crystals are major concerns within structural biology and p...
The ability to solve the structures of important proteins can be enhanced by increasing the probabil...
Bio-separation is a key bottleneck in the manufacture of biopharmaceuticals. In this work, we report...
In the past three decades, structural biology has developed tremendously with the establishment of t...
To overcome the laborious identification of crystallisation conditions for protein X-ray crystallogr...
The structure of proteins that are difficult to crystallize can often be solved by forming a noncova...
The protein crystallization process requires screening a large number of conditions using a large qu...
DARPin libraries, based on a Designed Ankyrin Repeat Protein consensus framework, are a rich source ...
The current, dominant method for structure determination in atomic detail is X-ray crystallography; ...
Novel tools and technologies are required to obtain structural information of difficult to crystalli...
Chymotrypsin is a protease that is commonly used as a standard for protein crystallization and as a ...
textHydrophobic membrane proteins perform a variety of important functions in the cell, but their st...
We show that knowledge of the phase behavior of a protein allows one to create a rational screen tha...
To date, X-ray crystallography remains the gold standard for the determination of macromolecular str...
Solving the structure of proteins is pivotal to achieving success in rational drug design and in oth...
Inherent difficulties in growing protein crystals are major concerns within structural biology and p...
The ability to solve the structures of important proteins can be enhanced by increasing the probabil...
Bio-separation is a key bottleneck in the manufacture of biopharmaceuticals. In this work, we report...
In the past three decades, structural biology has developed tremendously with the establishment of t...
To overcome the laborious identification of crystallisation conditions for protein X-ray crystallogr...
The structure of proteins that are difficult to crystallize can often be solved by forming a noncova...
The protein crystallization process requires screening a large number of conditions using a large qu...
DARPin libraries, based on a Designed Ankyrin Repeat Protein consensus framework, are a rich source ...
The current, dominant method for structure determination in atomic detail is X-ray crystallography; ...
Novel tools and technologies are required to obtain structural information of difficult to crystalli...
Chymotrypsin is a protease that is commonly used as a standard for protein crystallization and as a ...
textHydrophobic membrane proteins perform a variety of important functions in the cell, but their st...
We show that knowledge of the phase behavior of a protein allows one to create a rational screen tha...
To date, X-ray crystallography remains the gold standard for the determination of macromolecular str...
Solving the structure of proteins is pivotal to achieving success in rational drug design and in oth...
Inherent difficulties in growing protein crystals are major concerns within structural biology and p...
The ability to solve the structures of important proteins can be enhanced by increasing the probabil...
Bio-separation is a key bottleneck in the manufacture of biopharmaceuticals. In this work, we report...